SOURCE: OPTIMIZERx Corporation

September 02, 2015 08:00 ET

OptimizeRx Corporation to Present at the Liolios 4th Annual Gateway Conference on September 10, 2015

ROCHESTER, MI--(Marketwired - Sep 2, 2015) - OptimizeRx Corporation (OTCQB: OPRX), has been invited to present at the 2015 Gateway Conference being held on September 9-10, 2015 at the Four Seasons Hotel San Francisco.

David Harrell, OptimizeRx CEO, is scheduled to present on Thursday, September 10 at 11:00 a.m. Pacific time, with one-on-one meetings held throughout the conference. He will discuss the overall business expansion with both pharmaceutical partners and the expanding EHR and promotional network at point of care.

The presentation will be webcast live at http://wsw.com/webcast/liolios/oprx and available for replay in the Investor section of OptimizeRx Corporations website at www.optimizerxcorp.com or on the Gateway Conference website at www.gateway-conference.com/presenters.

To receive additional information, request an invitation or to schedule a one-on-one meeting, please email gateway@liolios.com.

About the Gateway Conference
The 4th Annual Gateway Conference is an invite-only conference presented by Liolios, which brings together the most compelling companies with the nation's top institutional investors and analysts. This year's event features more than 90 companies from a number of growth industries, including technology, business and financial services, consumer, digital media, clean technology and life sciences. The format has been designed to give attendees direct access to senior management via company presentations, Q&A sessions and one-on-one meetings. For more information, visit www.gateway-conference.com or www.liolios.com.

About OptimizeRx Corporation
OptimizeRx Corporation (OPRX) provides unique consumer and physician platforms to help patients better afford and comply with their medicines and healthcare products, while offering pharmaceutical and healthcare companies effective ways to expand awareness, access and adherence to their medications.

Our core product, SampleMD, replaces drug samples with electronic trial vouchers and copay coupon savings that are electronically added to an e-Prescription and sent electronically to the pharmacy and is integrated within leading Electronic Health Record (EHR) platforms in the country, including Allscripts, Quest Diagnostics, Practice Fusion and over 350 other EHRs to reach over 250,000 healthcare providers. In turn, we promote patients savings and support from the world's largest pharmaceutical companies, including Pfizer, Lilly, Novartis, AstraZeneca and many others. For more information, please go to www.optimizerxcorp.com.

Contact Information